Nimmagadda Prasad

Prasad contributed substantially towards the establishment of Pullela Gopi Chand’s badminton academy in its formative years

On 22 Sep 2016, Bahamas papers revealed that he has 28 secret companies at Secundrabad. Prasad and Prakash Nimmagadda, with interests in real estate to pharmaceuticals, is another set of names. Prasad is already being probed by the Central Bureau of Investigation in another case, which had also arrested him in May 2012, and got bail 17 months later, the newspaper said.

In the year 2015, Maa TV was acquired by Star TV, a wholly owned subsidiary of Rupert Murdoch-owned 21st Century Fox for a consideration of about Rs. 2,300 Crore.

In March 2014, in one of the largest criminal actions under the Prevention of Money Laundering Act, the Enforcement Directorate (ED) attached about 15 billion of assets of Nimmangada Prasad and his companies: G2 corporate Services Ltd, Alpha villas Pvt Ltd, Alpha Avenues Pvt Ltd, Gilchrist Investment Pvt Ltd, Suguni Constructions Pvt Ltd and Beta Avenues Pvt Ltd. ED claimed that Prasad had obtained illegal benefits of Rs 14261.7 million in his firms, and made the quid pro quo investment worth Rs 8545.4 million into Jagan Reddy's companies.

Subsequently, Prasad invested his capital in healthcare – CARE hospitals and Asian Institute of Gastroenterology. He also invested in stent manufacturer Relisys, and some genomic research-based companies. In the media business, he invested in MAA TV.

On 17 May 2012, Nimmagadda Prasad was questioned for several days and eventually arrested by the CBI. He was lodged in Chanchalguda jail, where he was always seen carrying a bottle of mineral water. After several failed attempts, he was eventually granted bail after seventeen months, in October 2013.

In 2008, Prasad joined as a local partner with the Government of Ras al-Khaimah for the implementing of a mega infrastructure project under the umbrella of VANPIC for the development of a world-class port-based integrated industrial corridor in the coastal region of Andhra Pradesh. This project was expected to transform the hitherto agri-based Guntur and Prakasam districts of Andhra Pradesh into major industrial hubs. With regards to VANPIC project, Prasad is embroiled in the alleged disproportionate assets case against Y S Jaganmohan Reddy, President of YSR Congress,

In a span of 6 years, Prasad built Matrix to a US$1.03 Billion value enterprise before it was acquired by US-based Mylan Inc. in 2006.

Prasad continued his entrepreneurial journey by acquiring Maa TV in 2006 and made it a leading Telugu General Entertainment Channel network. The revenue of the company has grown to Rs.350 Crores in 7 years.

In 2006, Prasad sold off his majority shares in Matrix Pharmaceutical to Mylan Laboratories, USA, a large generic Pharmaceutical Company. For his achievements, the state government has honoured him with the "Best Management Award" in 2006. On the other hand, in 2012, he was jailed during CBI's investigation on Y. S. Jaganmohan Reddy's Disproportionate Assets, for allegedly having paid Rs. 8.50 billion on a quid pro quo amounting to Rs 14261.7 million investments in VANPIC and other firms held by him, during Y. S. Rajasekhara Reddy's government. However, these assets were subsequently attached by the Enforcement Directorate of India, and Prasad was granted bail after seventeen months.

In 2006, Prasad sold off his majority shares in Matrix to Mylan Laboratories, USA, a large generic Pharmaceutical Company. From an initial investment of Rs. 30 million, Prasad retained 5% in Matrix, and made about Rs. 5.70 billion in the transaction in which Mylan picked up a 71.5% stake in Matrix laboratories.

With over 15 years of professional experience in multinational pharmaceutical environment, Prasad turned entrepreneur in the year 2000 by acquiring a sick pharmaceutical company in Hyderabad, and made it a great turnaround company, Matrix Laboratories Limited. With good product innovation, manufacturing scale, leadership, global marketing footprint and M&A Strategy, Prasad steered Matrix Laboratories as one of the major pharmaceutical companies in India.

In 2000, Prasad took over the sick pharmaceuticals company Herren Drugs, and renamed it Matrix Laboratories, and obtained US FDA clearance for the manufacturing facilities in Hyderabad. Matrix grew dramatically through a series of mergers and acquisitions. Prasad acquired Medicorp Technologies in May 2003, Vorin Labs in September 2003, Vera Laboratories, Fine Drugs & Chemicals the same year 2004 and a controlling stake in Concord Biotech in 2006. Prasad set his eyes on the global pharma-scape by acquiring Belgium-based Docpharma in June 2005, and a controlling stake in China's McChem Group. He also floated a JV South Africa's Aspen Pharmacare in September 2005, and picked 43% stake in Switzerland's Explora Laboratories SA the same year.

Prasad started his career as a management trainee in Indian Molasses Company in Delhi (an associate of United Molasses Company, UK) in 1984 and was promoted to salesman at Rhone Poulenc Chemicals (the company later merged with Hoechst AG to form Aventis, and then to Vorin Laboratories as general manager of marketing in 1993, from his continuous efforts was elevated to managing director in 1995. When Indian pharma market leader Ranbaxy Ltd. acquired Vorin, Prasad was re-designated Senior managing director and chief executive officer.

Nimmagadda Prasad (born 11 October 1961) is an Indian industrialist from Andhra Pradesh, India, known for his ventures in the Pharmaceutical and Television industries, and is involved in philanthropic activities through Nimmagadda Foundation.